BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 11474052)

  • 41. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA; Watkins KE
    Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescents with co-occurring mental health and substance use disorders in primary care.
    Gee RL; Espiritu RC; Huang LN
    Adolesc Med Clin; 2006 Jun; 17(2):427-52. PubMed ID: 16814701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of mental health care and substance abuse treatment among adults with co-occurring disorders.
    Harris KM; Edlund MJ
    Psychiatr Serv; 2005 Aug; 56(8):954-9. PubMed ID: 16088012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perceptions of behavioral health care among veterans with substance use disorders: results from a national evaluation of mental health services in the Veterans Health Administration.
    Blonigen DM; Bui L; Harris AH; Hepner KA; Kivlahan DR
    J Subst Abuse Treat; 2014 Aug; 47(2):122-9. PubMed ID: 24848543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unmet need for community-based mental health and substance use treatment among rural adolescents.
    Anderson RL; Gittler J
    Community Ment Health J; 2005 Feb; 41(1):35-49. PubMed ID: 15932051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Availability of behavioral health treatment for women in prison.
    Blitz CL; Wolff N; Paap K
    Psychiatr Serv; 2006 Mar; 57(3):356-60. PubMed ID: 16524993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perceived effectiveness of medications among mental health service users with and without alcohol dependence.
    Edlund MJ; Harris KM
    Psychiatr Serv; 2006 May; 57(5):692-9. PubMed ID: 16675765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Domains and perceived benefits of treatment among patients with and without co-occurring disorders in inpatient substance use treatment.
    Bergly TH; Gråwe RW; Hagen R
    J Dual Diagn; 2014; 10(2):91-7. PubMed ID: 25392251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.
    Timko C; Harris AHS; Jannausch M; Ilgen M
    Drug Alcohol Depend; 2019 Jan; 194():230-237. PubMed ID: 30466040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-occurring mental illness and substance use disorder among Australian prisoners.
    Butler T; Indig D; Allnutt S; Mamoon H
    Drug Alcohol Rev; 2011 Mar; 30(2):188-94. PubMed ID: 21355926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.
    Grella CE; Stein JA
    Psychiatr Serv; 2006 Jul; 57(7):1007-15. PubMed ID: 16816286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbid pathological gambling, mental health, and substance use disorders: Health-care services provision by clinician specialty.
    Rodriguez-Monguio R; Errea M; Volberg R
    J Behav Addict; 2017 Sep; 6(3):406-415. PubMed ID: 28856904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
    Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
    Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
    Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.